Michael Kauffman Insider Trading
Get free email notifications about insider trading for Michael Kauffman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael Kauffman. Michael Kauffman is a Director in INFINITY PHARMACEUTICALS, INC. ($INFI) and a Director in EPIRUS Biopharmaceuticals, Inc. ($CRXX) and an Chief Executive Officer in Karyopharm Therapeutics Inc. ($KPTI) and a Director in Verastem, Inc. ($VSTM) and a Director in Kezar Life Sciences, Inc. ($KZR).
Address: C/O COMBINATORX, INCORPORATED 245 FIRST STREET, 16TH FLOOR CAMBRIDGE 02142 MA
Companies in which Michael Kauffman is an Insider
EPIRUS Biopharmaceuticals, Inc.
Trading Symbol: CRXXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael Kauffman: Director
Holdings: 0 shares
Latest Transaction: Jun 05 2006
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INFINITY PHARMACEUTICALS, INC.
Trading Symbol: INFIIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael Kauffman: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 14 2019
$INFI Market Capitalization: $115.87M
$INFI Previous Close: $2.35
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Karyopharm Therapeutics Inc.
Trading Symbol: KPTIIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael Kauffman: Chief Executive Officer
Holdings: 714,826 shares
Current Value: $7,377,004
Latest Transaction: Mar 23 2021
$KPTI Market Capitalization: $416.55M
$KPTI Previous Close: $10.32
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kezar Life Sciences, Inc.
Trading Symbol: KZRIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael Kauffman: Director
Holdings: 63,690 shares
Latest Transaction: Jun 26 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Verastem, Inc.
Trading Symbol: VSTMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael Kauffman: Director
Holdings: 4,000 shares
Current Value: $4,960
Latest Transaction: Jun 18 2020
$VSTM Market Capitalization: $44.39M
$VSTM Previous Close: $1.24
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Michael Kauffman
Sentiment: All, CRXX, INFI, KPTI, KZR, VSTM
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 23 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 12.39 | 4,000 | 49,553 | 714,826 | 718.8 K to 714.8 K (-0.56 %) |
Mar 01 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 14.56 | 153,500 | 2,234,960 | 153,500 | |
Mar 01 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Option Exercise | A | 14.56 | 153,500 | 2,234,960 | 153,500 | |
Mar 01 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Grant | A | 0.00 | 57,200 | 0 | 920,152 | 863 K to 920.2 K (+6.63 %) |
Mar 01 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Grant | A | 0.00 | 57,200 | 0 | 718,826 | 661.6 K to 718.8 K (+8.65 %) |
Feb 22 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 14.83 | 9,495 | 140,822 | 776,452 | 785.9 K to 776.5 K (-1.21 %) |
Feb 22 2021 | KPTI | Karyopharm Therape ... | Kauffman Michael | Chief Executive Off ... | Sell | S | 14.83 | 9,495 | 140,822 | 575,126 | 584.6 K to 575.1 K (-1.62 %) |